Misako Nagasaka Mark Zaki Harold Kim S Naweed Raza George Yoo Ho-Sheng Lin Ammar Sukari
10.1186/s40425-016-0187-0
J Immunother Cancer
2016 Nov 15;4:83.
oral cancer pd1/pdl1 inhibitor radiation therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/27895920/
Antineoplastic Agents, Immunological / therapeutic use B7-H1 Antigen / antagonists & inhibitors Carcinoma, Squamous Cell / drug therapy Head and Neck Neoplasms / drug therapy Programmed Cell Death 1 Receptor / antagonists & inhibitors Radiation-Sensitizing Agents / therapeutic use
Antineoplastic Agents, Immunological / therapeutic use B7-H1 Antigen / antagonists & inhibitors Carcinoma, Squamous Cell / drug therapy Head and Neck Neoplasms / drug therapy Programmed Cell Death 1 Receptor / antagonists & inhibitors Radiation-Sensitizing Agents / therapeutic use Case Reports Aged Antineoplastic Agents, Immunological / pharmacology Carcinoma, Squamous Cell / diagnosis Carcinoma, Squamous Cell / mortality Carcinoma, Squamous Cell / radiotherapy Combined Modality Therapy Disease Progression Female Head and Neck Neoplasms / diagnosis Head and Neck Neoplasms / mortality Head and Neck Neoplasms / radiotherapy Humans Molecular Targeted Therapy Neoplasm Staging Radiation-Sensitizing Agents / pharmacology Recurrence Squamous Cell Carcinoma of Head and Neck Tomography, X-Ray Computed Treatment Outcome Antineoplastic Agents, Immunological B7-H1 Antigen CD274 protein, human Programmed Cell Death 1 Receptor Radiation-Sensitizing Agents
PMC5109767
27895920
PD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case report
2016